Effect of the adenosine A_2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatumGOŁEMBIOWSKA, Krystyna; DZIUBINA, Anna.Brain research. 2004, Vol 998, Num 2, pp 208-217, issn 0006-8993, 10 p.Article

Future Directions in the Treatment of Parkinson's DiseaseSCHAPIRA, Anthony H. V.Movement disorders. 2007, Vol 22, issn 0885-3185, S385-S391, SUP17Conference Paper

Reduced response to the formalin test and lowered spinal NMDA glutamate receptor binding in adenosine A_2A receptor knockout miceHUSSEY, Martin J; CLARKE, Geoffrey D; LEDENT, Catherine et al.Pain (Amsterdam). 2007, Vol 129, Num 3, pp 287-294, issn 0304-3959, 8 p.Article

Sustained improvement of motor function in hemiparkinsonian rats chronically treated with low doses of caffeine or trihexyphenidylBATA-GARCIA, José L; VILLANUEVA-TOLEDO, Jairo; GUTIERREZ-OSPINA, Gabriel et al.Pharmacology, biochemistry and behavior. 2007, Vol 86, Num 1, pp 68-78, issn 0091-3057, 11 p.Article

New adenosine A_2A receptor antagonists : Actions on Parkinson's disease modelsPINNA, Annalisa; VOLPINI, Rosaria; CRISTALLI, Gloria et al.European journal of pharmacology. 2005, Vol 512, Num 2-3, pp 157-164, issn 0014-2999, 8 p.Article

Blockade of A_2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulataCARTA, Anna R; MOJGAN AGHAZADEH TABRIZI; BARALDI, Pier G et al.Experimental neurology (Print). 2003, Vol 184, Num 2, pp 679-687, issn 0014-4886, 9 p.Article

Emerging therapies for Parkinson's disease: From bench to bedsideTARAZI, F. I; SAHLI, Z. T; WOLNY, M et al.Pharmacology & therapeutics (Oxford). 2014, Vol 144, Num 2, pp 123-133, issn 0163-7258, 11 p.Article

Gene knockout approach to adenosine A_2A receptors in Parkinson's diseaseCHEN, Jiang-Fan; SCHWARZSCHILD, Michael A.Drug development research. 2003, Vol 58, Num 4, pp 354-367, issn 0272-4391, 14 p.Conference Paper